A new study found that the risk of a rare condition of blood clotting cerebral venous thrombosis (CVT) was not increased after coronavirus infection after inoculation to Covid-19.
Researchers at the University of Oxford in the UK have counted CVT cases, two weeks after the detection of Kovid-19 and the first dose of the vaccine. He compared these cases to CVT cases occurring after influenza and its pre-existing levels in the general population.
A team of researchers found that CVT occurs more frequently than any other condition after COVID-19, with 30 percent of cases occurring in those under 30 years of age. The risk is eight to 10 times higher compared to the existing Kovid-19 vaccine, and about 100 times more without vaccines, he said.
Vaccines and CVT Concerns:
Paul Harrison, head of the Oxford University Translational Neurobiology Group, said there were concerns about the potential link between vaccines and CVT, which would limit the use of certain vaccines by governments and regulators. Harrison has not yet answered a question, what is the risk of CVT after Kovid-19?
Researchers found that the risk of CVT increases significantly after Kovid-19, and there are other problems associated with the formation of blood clots from the disease, which are exacerbated.
In this study, the risk of coronavirus infection by touching the surface is very low.
Disclaimer: The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.
